Hepatic Arterial Infusion Chemotherapy Combined Lenvatinib and PD-1 Inhibitor Showed Improved Survival for Infiltrative Hepatocellular Carcinoma: A Multicenter Cohort Study.

Ruixia LiXiao-Hui WangHui LiMurong WangJuncheng WangWei WangQunfang Zhou

Published in: Journal of hepatocellular carcinoma (2024)

Patient with infiltrative HCC, HAIC+Len+PD-1 treatment had longer OS and PFS than Len+PD-1 treatment. Early AFP response was an effective indicator of better survival and tumor response to therapy.

Keyphrases

low dose
clinical trial
stem cells
radiation therapy
mesenchymal stem cells
locally advanced
double blind